Mule Regulates the Intestinal Stem Cell Niche via the Wnt Pathway and Targets EphB3 for Proteasomal and Lysosomal Degradation

The E3 ubiquitin ligase Mule is often overexpressed in human colorectal cancers, but its role in gut tumorigenesis is unknown. Here, we show in vivo that Mule controls murine intestinal stem and progenitor cell proliferation by modulating Wnt signaling via c-Myc. Mule also regulates protein levels of the receptor tyrosine kinase EphB3 by targeting it for proteasomal and lysosomal degradation. In the intestine, EphB/ephrinB interactions position cells along the crypt-villus axis and compartmentalize incipient colorectal tumors. Our study thus unveils an important new avenue by which Mule acts as an intestinal tumor suppressor by regulation of the intestinal stem cell niche

Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer

Pancreatic stellate cells (PSCs) differentiate into cancer-associated fibroblasts (CAFs) that produce desmoplastic stroma, thereby modulating disease progression and therapeutic response in pancreatic ductal adenocarcinoma (PDA). However, it is unknown whether CAFs uniformly carry out these tasks or if subtypes of CAFs with distinct phenotypes in PDA exist. We identified a CAF subpopulation with elevated expression of alpha-smooth muscle actin (alphaSMA) located immediately adjacent to neoplastic cells in mouse and human PDA tissue. We recapitulated this finding in co-cultures of murine PSCs and PDA organoids, and demonstrated that organoid-activated CAFs produced desmoplastic stroma. The co-cultures showed cooperative interactions and revealed another distinct subpopulation of CAFs, located more distantly from neoplastic cells, which lacked elevated alphaSMA expression and instead secreted IL6 and additional inflammatory mediators. These findings were corroborated in mouse and human PDA tissue, providing direct evidence for CAF heterogeneity in PDA tumor biology with implications for disease etiology and therapeutic development

TRADD Mediates Inflammatory Responses in the Cytoplasm and Tumor Suppression in the Nucleus

TNF is a proinflammatory cytokine whose pleiotropic biological properties are signaled through the receptor TNFR1. Activation of this signaling pathway has been implicated in a broad range of biological functions, including host defense, inflammation, apoptosis, autoimmunity, and cancer. TRADD is an adaptor protein that is recruited to TNFR1 upon receptor engagement. Using a Tradd-deficient murine model, we demonstrated that TRADD is essential for both TNF-mediated apoptosis and inflammatory responses. In addition to refining the role of TRADD in TNFR1 signaling, we have also identified a novel function of TRADD in TLR3 and TLR4 pathways, which are key drivers of the innate immune response. We showed that TRADD is involved in NF-κB activation upon TLR3 and TLR4 stimulation, and Tradd-deficient macrophages showed impaired inflammatory cytokine production in response to TLR ligands in vitro. These data reveal the multifaceted functions of TRADD in immune signaling pathways. Beyond its role in the immune response, TNF has also been shown to play a crucial, cell-non-autonomous role in driving tumor growth in various models of cancer. We initially sought to determine whether TRADD is essential for this aspect of TNF function by employing the use of a chemical induced skin carcinogenesis model in which the tumor-promoting role of TNF is very well established. In this model, H-Ras is the major driving oncogene. We found that Tradd deficiency accelerated tumor formation in mouse skin, in strong contrast to what was observed in Tnfr1-deficient mice. Further in vitro analyses revealed that upon expression of oncogenic H-Ras, Tradd-deficient murine fibroblasts displayed both reduced cell cycle arrest and repression of Ras induced cellular senescence. Importantly, the level of p19Arf induced by H-Ras expression was reduced in Tradd-deficient fibroblasts in a post-translational manner. Our biochemical evidence suggests that TRADD can shuttle dynamically between the cytoplasm and the nucleus; in doing so, nuclear TRADD interacts with ULF, a newly identified E3 ubiquitin ligase for p19Arf. Interaction between nuclear TRADD and ULF sequesters ULF away from p19Arf, leading to p19Arf stabilization and tumor suppression. Together, these data demonstrate the functional diversity of TRADD in different compartments of the cell.Ph

ROS in Cancer: The Burning Question

An unanswered question in human health is whether antioxidation prevents or promotes cancer. Antioxidation has historically been viewed as chemopreventive, but emerging evidence suggests that antioxidants may be supportive of neoplasia. We posit this contention to be rooted in the fact that ROS do not operate as one single biochemical entity, but as diverse secondary messengers in cancer cells. This cautions against therapeutic strategies to increase ROS at a global level. To leverage redox alterations towards the development of effective therapies necessitates the application of biophysical and biochemical approaches to define redox dynamics and to functionally elucidate specific oxidative modifications in cancer versus normal cells. An improved understanding of the sophisticated workings of redox biology is imperative to defeating cancer

D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function

Isocitrate dehydrogenase-1 (IDH1) R132 mutations occur in glioma, but their physiological significance is unknown. Here we describe the generation and characterization of brain-specific Idh1 R132H conditional knockin (KI) mice. Idh1 mutation results in hemorrhage and perinatal lethality. Surprisingly, intracellular reactive oxygen species (ROS) are attenuated in Idh1-KI brain cells despite an apparent increase in the NADP+/NADPH ratio. Idh1-KI cells also show high levels of D-2-hydroxyglutarate (D2HG) that are associated with inhibited prolyl-hydroxylation of hypoxia-inducible transcription factor-1?? (Hif1??) and up-regulated Hif1?? target gene transcription. Intriguingly, D2HG also blocks prolyl-hydroxylation of collagen, causing a defect in collagen protein maturation. An endoplasmic reticulum (ER) stress response induced by the accumulation of immature collagens may account for the embryonic lethality of these mutants. Importantly, D2HG-mediated impairment of collagen maturation also led to basement membrane (BM) aberrations that could play a part in glioma progression. Our study presents strong in vivo evidence that the D2HG produced by the mutant Idh1 enzyme is responsible for the above effects. © 2012 by Cold Spring Harbor Laboratory Press.close71696

A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinoma

The changes in super-enhancer (SE) landscape of cancers are mainly attributed to cell-intrinsic genomic alterations. Here, the authors perform epigenomic profiling on primary colorectal cancers (CRCs) and their matched normal tissues and show that local tumour microenvironment induces a SE activation and that its target, PDZK1IP1 promotes CRC growth